Abstract

Background: We aimed to explore the genetic correlation and bidirectional causal relationships between low back pain (LBP) and three neurodegenerative diseases, Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS).Methods: Summary-level statistics were obtained from genome-wide association studies of LBP (n = 177,860), AD (n = 63,926), PD (n = 482,730), and ALS (n = 80,610). We implemented linkage disequilibrium score regression to calculate heritability estimates and genetic correlations. To investigate possible causal associations between LBP and three neurodegenerative diseases, we also conducted a bidirectional two-sample Mendelian randomization (MR) study. Inverse variance-weighted MR was employed as the primary method to generate overall estimates, whereas complementary approaches and sensitivity analyses were conducted to confirm the consistency and robustness of the findings.Results: There was no evidence of genetic correlations between LBP and AD (Rg = −0.033, p = 0.766). MR analyses did not support the causal effect of LBP on AD (OR = 1.031; 95% CI, 0.924–1.150; p = 0.590) or the effect of AD on LBP (OR = 0.963; 95% CI, 0.923–1.006; p = 0.090). Likewise, this study failed to identify genetic correlations between LBP and two other neurodegenerative diseases. MR results of the associations of LBP with PD and ALS, and the reverse associations, did not reach Bonferroni-corrected significance.Conclusion: The study did not support genetic correlations or causations between LBP and three common neurodegenerative diseases, AD, PD, and ALS in the European population.

Highlights

  • Neurodegenerative diseases have imposed a heavy burden on the global healthcare in line with the accelerated trend of population aging

  • In the genome-wide association studies (GWAS) of Low back pain (LBP), genomic inflation factor demonstrated slight inflation; with the intercept (1.035) being close to 1, the inflation should be attributed to the polygenic genetic architecture

  • There was no evidence for the genetic correlation between LBP and Alzheimer’s disease (AD) (Rg = −0.033, p = 0.766)

Read more

Summary

Introduction

Neurodegenerative diseases have imposed a heavy burden on the global healthcare in line with the accelerated trend of population aging. Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is the most common type of motor neuron disease (Hardiman et al, 2017; Liu et al, 2018). With their etiology and mechanism largely unknown, there are no effective treatments to slow down the progression of neurodegenerative diseases so far (Dorst et al, 2018; Piton et al, 2018; de Bie et al, 2020). We aimed to explore the genetic correlation and bidirectional causal relationships between low back pain (LBP) and three neurodegenerative diseases, Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call